Anebulo Pharmaceuticals, Inc. SEC filings ANEB
Anebulo Pharmaceuticals, Inc. has 204 filings in SEC EDGAR's recent list, going back to Jun 25, 2020. Its latest annual report, Form 10-K, was filed on Sep 29, 2025 for the period ended Jun 30, 2025. The latest quarterly report (Form 10-Q) was filed on Feb 12, 2026, covering the quarter ended Dec 31, 2025. The most recent current report (Form 8-K) was filed on Feb 12, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | Mar 2, 2026 | — |
| 25 | Filing | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Jan 8, 2026 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2025 | — |
| SC TO-I | Filing | Dec 22, 2025 | — |
| CORRESP | Letter to the SEC | Oct 10, 2025 | — |
| PRER14A | Filing | Oct 10, 2025 | — |
| EFFECT | Filing | Sep 23, 2025 | — |
| EFFECT | Filing | Sep 23, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 15, 2025 | — |
| PRER14A | Filing | Sep 15, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2025 | — |
| EFFECT | Filing | Feb 28, 2025 | — |
| CORRESP | Letter to the SEC | Feb 26, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2025 | — |
| D | Filing | Dec 31, 2024 | — |
| EFFECT | Filing | Nov 10, 2022 | — |
| CORRESP | Letter to the SEC | Nov 8, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2022 | — |
| DEFR14A | Filing | Oct 25, 2022 | — |
| D | Filing | Oct 11, 2022 | — |
| CERT | Filing | May 7, 2021 | — |
| EFFECT | Filing | May 6, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| 8-A12B | Filing | May 5, 2021 | — |
| CORRESP | Letter to the SEC | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | May 4, 2021 | — |
| CORRESP | Letter to the SEC | Apr 26, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2021 | — |
| CORRESP | Letter to the SEC | Apr 1, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2021 | — |
| DRS/A | Filing | Mar 12, 2021 | — |
| DRSLTR | Filing | Mar 11, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 26, 2021 | — |
| DRSLTR | Filing | Jan 29, 2021 | — |
| DRS | Filing | Jan 29, 2021 | — |
| D | Filing | Jun 25, 2020 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANEB (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Lakeway, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1815974
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.